Eagle Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Woodcliff Lake NJ United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2008
NCT01045018
First Marketed Drug
2011
argatroban
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Eagle Pharmaceuticals, Inc. | EAGLE PHARMS